Stimulation of Human Immunodeficiency Virus Type 1 HIV-1 Specific Cytolytic Effector Function Using Allogeneic Cell Immunotherapy

Status	Finished
Effective start/end date	1/01/12 → 31/12/15

Access Project

Drug-induced alloreactivity: A new paradigm for allorecognition
D'Orsogna, L. J., Almeida, C. A. M., van Miert, P., Zoet, Y. M., Anholts, J. D. H., Chopra, A., Watson, M., Witt, C., John, M. & Claas, F. H. J., 24 May 2019, (E-pub ahead of print) In: American Journal of Transplantation. 19, 9, p. 2606-2613 8 p.
Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus)
Virus-specific T-cell clonotypes might contribute to drug hypersensitivity reactions through heterologous immunity
Almeida, C. A., van Miert, P., O'Driscoll, K., Zoet, Y. M., Chopra, A., Witt, C., John, M., Claas, F. H. J. & D'Orsogna, L. J., Aug 2019, In: Journal of Allergy and Clinical Immunology. 144, 2, p. 608-611.e4
Research output: Contribution to journal › Letter › peer-review

15 Citations (Web of Science)
Stimulation of HIV-specific T cell clonotypes using allogeneic HLA
Almeida, C. A., van Miert, P., O'Driscoll, K., Zoet, Y. M., Chopra, A., Watson, M., de Santis, D., Witt, C., John, M., Claas, F. H. J. & D'Orsogna, L. J., Jun 2017, In: Cellular Immunology. 316, p. 32-40 9 p.
Research output: Contribution to journal › Article › peer-review
9 Citations (Scopus)